The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 360:2675-2678 June 18, 2009 Number 25
NextNext

Melamine-Contaminated Powdered Formula and Urolithiasis

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Langman, C. B.
-Related Article
-Related Article
 by Guan, N.
-PubMed Citation
To the Editor: The article by Guan et al.,1 the accompanying editorial by Langman,2 and the letter to the Editor by Wang et al.3 (all in the March 12 issue) provide information about the epidemiology of pediatric nephrolithiasis caused by melamine poisoning. Here we supplement those data and commentary with information regarding diagnosis and treatment on the basis of our clinical experience and the advice of the Chinese Ministry of Health.4,5

Kidney stones that have formed as a result of melamine poisoning differ from the more commonly encountered radiopaque stones containing calcium oxalate and phosphate in that they are radiolucent and not revealed by standard radiography.4 In light of these distinctions, B-scan ultrasonography should be used to detect kidney stones in children who have consumed milk that is suspected of being contaminated with melamine.4 Kidney stones that are associated with melamine poisoning commonly affect the collecting system and ureters bilaterally, predominantly at the ureteropelvic and ureter–bladder junctions.4 The urinary tract may be extensively obstructed.4 The stones can affect large areas and produce a light background echo.4 Our recommended courses of action, depending on the degree of severity of nephrolithiasis, are summarized in Figure 1.

Figure 1
View larger version (28K):
[in this window]
[in a new window]
Get Slide
 
Figure 1. Treatments for Pediatric Nephrolithiasis Caused by Melamine Poisoning as Recommended by the Chinese Ministry of Health.

 


Kunmei Ji, Ph.D.
Shenzhen University
Shenzhen 518060, China


Shenglang Zhu, M.D.
Shenzhen Nanshan Hospital
Shenzhen 518052, China


Zhigang Liu, M.D.
Shenzhen University
Shenzhen 518060, China
lzg{at}szu.edu.cn

References

  1. Guan N, Fan Q, Ding J, et al. Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med 2009;360:1067-1074. [Free Full Text]
  2. Langman CB. Melamine, powdered milk, and nephrolithiasis in Chinese infants. N Engl J Med 2009;360:1139-1141. [Free Full Text]
  3. Wang I-J, Chen P-C, Hwang K-C. Melamine and nephrolithiasis in children in Taiwan. N Engl J Med 2009;360:1157-1158. [Free Full Text]
  4. Ministry of Health of the People's Republic of China. Medical treatment of infants affected by Sanlu melamine-contaminated milk powder. The Chinese Ministry of Health Bulletin. October 15, 2008. (Accessed May 28, 2009, at http://www.moh.gov.cn.) (In Chinese.)
  5. Idem. Proposed therapy for infants affected by melamine-contaminated milk powder. September 12, 2008. (Accessed May 28, 2009, at http://www.moh.gov.cn.) (In Chinese.)

 
To the Editor: The report by Guan et al. regarding infants who consumed melamine-contaminated formula states that the increase in the relative risk of stones was lower in preterm infants (odds ratio, 4.5) than in term infants (odds ratio, 7.0). As noted in the accompanying editorial, preterm infants generally have a higher risk of stones, in part because of a decreased rate of excretion of urinary inhibitors of stone formation. If we assume there was an equal likelihood of ingesting the tainted formula and an equal duration of exposure among all infants, preterm infants in this study should have been at higher risk than term infants. Were the preterm infants seen at a younger age than term infants, when they might still be under a gestational age of 40 weeks? At that stage of development, with lower urine-concentrating capacity, their ability to exceed solubility products in urine might be poor. Alternatively, among preterm infants, the duration of exposure, a factor in the study by Wang et al., might have been less. It would also be interesting to know whether preterm infants made up a greater proportion of those with glomerular dysfunction, since these infants might have had reversible glomerular albuminuria from prematurity itself.1


Vikas R. Dharnidharka, M.D., M.P.H.
University of Florida
Gainesville, FL 32610-0296
vikasmd{at}peds.ufl.edu

References

  1. Tsukahara H, Fujii Y, Tsuchida S, et al. Renal handling of albumin and beta-2-microglobulin in neonates. Nephron 1994;68:212-216. [CrossRef][Web of Science][Medline]

 
To the Editor: In his editorial, Langman discusses the three reports of renal injury from melamine. Other health effects may be worth considering in light of the molecular composition of melamine (Figure 1). Melamine is a triazine (1,3,5-triazine–2,4,6-triamine). Atrazine is a chlorinated triazine (2-chloro-4-[ethylamine]-6-[isopropylamine]-s-triazine) and is used extensively as a broadleaf herbicide in the Midwest and elsewhere in the world, although its use is banned in Europe. Atrazine has been associated with reproductive malformations, such as hermaphroditism in amphibians.1,2 Long-term screening for reproductive ill effects in babies who have been exposed to melamine-adulterated formula may be warranted. Conversely, studies on the health of agricultural workers using atrazine should include an assessment of renal colic and kidney failure.

Figure 2
View larger version (14K):
[in this window]
[in a new window]
Get Slide
 
Figure 1. Molecular Structures of Melamine and Atrazine.

 


Bruce Hocking, M.B., B.S.
9 Tyrone St.
Camberwell, VIC 3124, Australia
bruhoc{at}connexus.net.au

References

  1. Hayes T, Haston K, Tsui M, Hoang A, Haeffele C, Vonk A. Atrazine-induced hermaphroditism at 0.1 ppb in American leopard frogs (Rana pipiens): laboratory and field evidence. Environ Health Perspect 2003;111:568-575. [Web of Science][Medline]
  2. Mizota K, Ueda H. Endocrine disrupting chemical atrazine causes degranulation through Gq/11 protein-coupled neurosteroid receptor in mast cells. Toxicol Sci 2006;90:362-368. [Free Full Text]

 
The authors reply: Ji et al. state that kidney stones that are associated with melamine contamination are usually radiolucent, which was the case in our study. We emphasized that melamine-associated urolithiasis should be diagnosed by ultrasonography rather than by radiographic studies. Because ureteropelvic and ureterovesical junctions are relatively narrow, obstruction occurred more easily in these regions.1 We believe that this is characteristic of all types of stones, not just those associated with the ingestion of melamine. For diagnostic purposes, since laboratory investigation often occurred after obstruction, we believe that imaging with ultrasonography is the most important technique for diagnosis and for making clinical decisions. For the children with renal failure induced by obstruction, the most important action is to relieve the obstruction.2

Dharnidharka notes that preterm infants are generally more prone to all types of stones than are term infants. In our study, 7 preterm infants and 29 full-term infants had urinary stones. The average ages were 1.56±0.84 years for preterm infants and 1.74±0.72 years for full-term infants. There was no significant difference between the ages of the two groups. However, the percentage of preterm infants who were less than 40 weeks old was higher than that of full-term infants (28.6% vs. 3.4%, P=0.09). There was no significant difference between preterm infants and full-term infants in the time of exposure to melamine-contaminated formula. There was also no significant difference in the rate of glomerular dysfunction between the preterm infants (4%) and the full-term infants (9%), which suggests that glomerular dysfunction was not associated with the immaturity of the preterm infants.


Na Guan, M.D., Ph.D.
Jie Ding, M.D., Ph.D.
Peking University First Hospital
Beijing 100034, China
djnc_5855{at}126.com

References

  1. Dursun I, Poyrazoglu HM, Dusunsel R, et al. Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 2008;40:3-9. [CrossRef][Web of Science][Medline]
  2. Sarica K. Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 2006;34:96-101. [CrossRef][Web of Science][Medline]

 
The editorialist replies: We do not have substantial epidemiologic data and mechanistic explanations regarding melamine-associated kidney stones in infants caused by tainted powdered formula. Only very recently has it been feasible to measure urinary melamine and its metabolites easily; such capability may help define the risk of stones from dietary exposure.1

With respect to the recommendations of Ji and colleagues, I have several concerns. I do not expect that a fully obstructed urinary tract with stones would be asymptomatic in young infants. Such affected infants would probably show a lack of normal health, appetite, and growth, with symptoms such as irritability, urinary infection, gross hematuria, and stone colic. Certainly, no infants should continue to receive tainted formula, and without additional exposure, newly diagnosed cases will cease, since melamine is not stored in or released from body tissues.

What then should the medical community do about the infants who were exposed? Without evidence of an ongoing epidemic of new kidney stones or new cases of melamine-related acute kidney failure, a conservative approach to care has been supported by pediatric nephrologists internationally.2

With respect to Hocking's comments: although there are reports of urinary epithelial neoplasia in rats that receive dietary melamine in high doses and of its modulation by dietary polyunsaturated fatty acid,3 we do not have a clear understanding of these relationships. Simple chemical similarities of structure may not predict similar actions (e.g., retinoid compounds in skin disorders).4 A melamine-like triazine compound may be antineoplastic, and cyanuric acid salts are nonmutagenic. Atrazine has not been linked to nephrolithiasis. However, experimental studies have shown that atrazine induces insulin resistance and alters mitochondrial functions,5 which may be associated with an increased risk of kidney stones. Agricultural workers may have additional environmental risk factors for kidney stones, including chronic volume depletion and high levels of dietary fructose.


Craig B. Langman, M.D.
Children's Memorial Hospital
Chicago, IL 60614

References

  1. Tang HW, Ng KM, Chui SS, et al. Analysis of melamine cyanurate in urine using matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 2009;81:3676-3682. [Medline]
  2. Langman CB, Alon U, Ingelfinger J, et al. A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infants. Pediatr Nephrol 2009 February 7 (Epub ahead of print).
  3. Cremonezzi DC, Díaz MP, Valentich MA, Eynard AR. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food Chem Toxicol 2004;42:1999-2007. [CrossRef][Web of Science][Medline]
  4. Desai A, Kartono F, Del Rosso JQ. Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy. Dermatol Clin 2007;25:185-193. [CrossRef][Web of Science][Medline]
  5. Lim S, Ahn SY, Song IC, et al. Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS ONE 2009;4:e5186-e5186. [CrossRef][Medline]

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Langman, C. B.
-Related Article
-Related Article
 by Guan, N.
-PubMed Citation

Related Letters:

Melamine and Nephrolithiasis in Children in Taiwan
Wang I-J., Chen P.-C., Hwang K.-C.
Extract | Full Text | PDF  
N Engl J Med 2009; 360:1157-1158, Mar 12, 2009; published at www.nejm.org on Feb 4, 2009 (10.1056/NEJMc0810070). Correspondence



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.